Substrates of Sudden Cardiac Death in Hypertrophic Cardiomyopathy

Area of Science:

• Cardiology
• Electrophysiology
• Genetics

Background:

• Sudden cardiac death (SCD) is a major risk in hypertrophic cardiomyopathy (HCM).
• Ventricular arrhythmias, such as tachycardia and fibrillation, are primary triggers for SCD in HCM patients.
• Current understanding of the mechanisms driving ventricular arrhythmias in HCM is incomplete, involving multiple pro-arrhythmic factors.

Purpose of the Study:

• To explore the contribution of cellular, structural, and electrophysiological substrates to arrhythmic risk in HCM.
• To highlight the potential of substrate-based approaches for refining SCD prevention strategies.
• To improve outcomes for patients diagnosed with HCM.

Main Methods:

• Review of existing literature on hypertrophic cardiomyopathy, sudden cardiac death, and ventricular arrhythmias.
• Analysis of the roles of myocyte disarray, myocardial fibrosis, and cellular abnormalities in arrhythmogenesis.
• Discussion of traditional risk prediction models versus emerging substrate-based assessment techniques.

Main Results:

• Myocyte disarray and myocardial fibrosis create a substrate for re-entrant arrhythmias by altering electrophysiological properties.
• Cellular abnormalities are significant in patients lacking evident structural remodeling.
• Emerging techniques enable direct assessment of arrhythmic substrates, offering deeper mechanistic insights.

Conclusions:

• Substrate-based approaches offer a promising avenue for personalized SCD risk stratification in HCM.
• Identifying specific arrhythmic substrates can lead to more effective prevention strategies.
• A comprehensive understanding of cellular, structural, and electrophysiological factors is crucial for managing HCM and reducing SCD risk.